Piedmont Investment Advisors’s Natus Medical Inc NTUS Stock Holding History

Piedmont Investment Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,406	Closed	-$213K	–	1322
2019 Q1	$213K	Buy	8,406 +387	+5%	+$11.5K	0.01%	1040
2018 Q4	$273K	Buy	8,019 +333	+4%	+$10.8K	0.01%	781
2018 Q3	$274K	Sell	7,686 -92	-1%	-$3.25K	0.01%	823
2018 Q2	$268K	Buy	7,778 +690	+10%	+$24.2K	0.01%	697
2018 Q1	$239K	Buy	7,088 +684	+11%	+$21.6K	0.01%	649
2017 Q4	$245K	Sell	6,404 -818	-11%	-$32.7K	﹤0.01%	641
2017 Q3	$271K	Sell	7,222 -48,318	-87%	-$1.71M	0.01%	618
2017 Q2	$2.07M	Buy	55,540 +14,508	+35%	+$524K	0.05%	266
2017 Q1	$1.61M	Buy	41,032 +24,132	+143%	+$905K	0.03%	263
2016 Q4	$588K	Buy	+16,900	New	+$663K	0.01%	299

Other funds holding NTUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Piedmont Investment Advisors's NTUS Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Natus Medical Inc (NTUS) in Q2 2019, closing a stake of 8,406 shares — an estimated $213K sold.

Piedmont Investment Advisors first reported a position in NTUS in Q4 2016 and held it in 10 quarters. The position peaked at $2.07M in Q2 2017. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2019.

Piedmont Investment Advisors reported no remaining Natus Medical Inc position as of Q2 2019 after selling out during the quarter.
Piedmont Investment Advisors sold 8,406 Natus Medical Inc shares in Q2 2019, an estimated $213K.
Piedmont Investment Advisors first reported a position in Natus Medical Inc in Q4 2016 and held it in 10 quarters.
Piedmont Investment Advisors's Natus Medical Inc position peaked at $2.07M in Q2 2017.
175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.